NATALIYA PONTONE: Open Payments
NPI 1508147208 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,036 in 114 payments from 16 companies in 2025. Trend: 2023 $144 · 2024 $1,069 · 2025 $3,036
Food & beverage: $3,033Education: $2
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 33 | $954 |
| Lundbeck LLC | 17 | $464 |
| ABBVIE INC. | 12 | $338 |
| Axsome Therapeutics, Inc. | 9 | $248 |
| Vanda Pharmaceuticals Inc. | 16 | $238 |
| E.R. Squibb & Sons, L.L.C. | 7 | $223 |
| Alkermes, Inc. | 5 | $148 |
| Janssen Pharmaceuticals, Inc | 3 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
Products named: REXULTI, ABILIFY ASIMTUFII, VRAYLAR, Auvelity, FANAPT, COBENFY, LYBALVI, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
